Danazol
-
Post Date:
Dec 07,2016
-
Expiry Date:
Dec 14,2016
-
Detailed Description:
Cas No. :17230-88-5
Quantity: 100Kilograms
Payment Method: Western union, money gram, T/T
Indications:
Danazol has been used-mostly off-label-for other indications, namely in the management of menorrhagia, fibrocystic breast disease, immune thrombocytopenic purpura ,premenstrual syndrome, breast pain (mastodynia) and hereditary angioedema.Although not currently a standard treatment for menorrhagia, danazol has resulted in significant relief in young women with menorrhagia in a study, and, because of a lack of significant adverse effects, it was proposed as an alternative treatment.Low-dose danazol has also been investigated in the treatment of diabetic macular edema in a phase 3 trial.
-
CAS Registry Number:
17230-88-5
-
Synonyms:
;Hydrocortisonum micr.;17-alpha-2,4-pregnadien-20-yno(2,3-d)isoxazol-17-ol;17-alpha-pregn-4-en-20-yno(2,3-d)isoxazol-17-ol;3-d)isoxazol-17-ol,(17-alpha)-pregna-4-dien-20-yno(2;danazole;danocrine;danol;win17757;DANZOL;(1R,3aS,3bR,10aR,10bS,12aS)-1-ethynyl-10a,12a-dimethyl-2,3,3a,3b,4,5,10,10a,10b,11,12,12a-dodecahydro-1H-cyclopenta[7,8]phenanthro[3,2-d][1,2]oxazol-1-ol;(1R,10aR,12aS)-1-ethynyl-10a,12a-dimethyl-2,3,3a,3b,4,5,10,10a,10b,11,12,12a-dodecahydro-1H-cyclopenta[7,8]phenanthro[3,2-d]isoxazol-1-ol;(1R,3aS,3bR,10bS)-1-ethynyl-10a,12a-dimethyl-2,3,3a,3b,4,5,10,10a,10b,11,12,12a-dodecahydro-1H-cyclopenta[7,8]phenanthro[3,2-d][1,2]oxazol-1-ol;
-
Molecular Formula:
C22H27NO2
-
Molecular Weight:
337.4553
-
Molecular Structure:
-
Hazard Symbols:
Xn:Harmful;
-
Risk Codes:
R20/21/22:;
R63:;
-
Safety Description:
S22:;
S36:;
-
Company:
HUBEI YUANCHENG SAICHUANG TECHNOLOGY CO., LTD
[ China ]
-
Contact:
Catherine Lee
-
Tel:
+86-18872220686
-
Fax:
86-027-68886696
-
Email:
2355916854@ycphar.com
Inquiry